DELSTRIGO 100 mg/1
doravirine, lamivudine, and tenofovir disoproxil fumarate · TABLET, FILM COATED · Merck Sharp & Dohme LLC
DELSTRIGO is a tablet, film coated containing doravirine, lamivudine, and tenofovir disoproxil fumarate at 100 mg/1, taken oral. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- DELSTRIGO
- Generic Name
- doravirine, lamivudine, and tenofovir disoproxil fumarate
- NDC Code (Product)
0006-5007- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 100 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA210807
- Drug Class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 07/20/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is DELSTRIGO used for?
DELSTRIGO contains doravirine, lamivudine, and tenofovir disoproxil fumarate. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is DELSTRIGO a controlled substance?
DELSTRIGO is not classified as a controlled substance by the DEA.
What is the generic name for DELSTRIGO?
The generic name for DELSTRIGO is doravirine, lamivudine, and tenofovir disoproxil fumarate. There are no other listed brand versions of doravirine, lamivudine, and tenofovir disoproxil fumarate.
What is the NDC code for DELSTRIGO 100 mg/1?
The NDC (National Drug Code) for DELSTRIGO 100 mg/1 is 0006-5007, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)